BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 17255298)

  • 1. Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.
    Thompson RH; Dong H; Kwon ED
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):709s-715s. PubMed ID: 17255298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of B7-H1 overexpression in kidney cancer.
    Thompson RH; Kwon ED
    Clin Genitourin Cancer; 2006 Dec; 5(3):206-11. PubMed ID: 17239274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
    Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Chen L; Zincke H; Blute ML; Leibovich BC; Kwon ED
    Cancer; 2005 Nov; 104(10):2084-91. PubMed ID: 16208700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.
    Thompson RH; Kuntz SM; Leibovich BC; Dong H; Lohse CM; Webster WS; Sengupta S; Frank I; Parker AS; Zincke H; Blute ML; Sebo TJ; Cheville JC; Kwon ED
    Cancer Res; 2006 Apr; 66(7):3381-5. PubMed ID: 16585157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma.
    Thompson RH; Webster WS; Cheville JC; Lohse CM; Dong H; Leibovich BC; Kuntz SM; Sengupta S; Kwon ED; Blute ML
    Urology; 2005 Nov; 66(5 Suppl):10-4. PubMed ID: 16194701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
    Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
    Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
    Krambeck AE; Dong H; Thompson RH; Kuntz SM; Lohse CM; Leibovich BC; Blute ML; Sebo TJ; Cheville JC; Parker AS; Kwon ED
    Clin Cancer Res; 2007 Mar; 13(6):1749-56. PubMed ID: 17363528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy.
    Roth TJ; Sheinin Y; Lohse CM; Kuntz SM; Frigola X; Inman BA; Krambeck AE; McKenney ME; Karnes RJ; Blute ML; Cheville JC; Sebo TJ; Kwon ED
    Cancer Res; 2007 Aug; 67(16):7893-900. PubMed ID: 17686830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.
    Inman BA; Sebo TJ; Frigola X; Dong H; Bergstralh EJ; Frank I; Fradet Y; Lacombe L; Kwon ED
    Cancer; 2007 Apr; 109(8):1499-505. PubMed ID: 17340590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.
    Siddiqui SA; Frigola X; Bonne-Annee S; Mercader M; Kuntz SM; Krambeck AE; Sengupta S; Dong H; Cheville JC; Lohse CM; Krco CJ; Webster WS; Leibovich BC; Blute ML; Knutson KL; Kwon ED
    Clin Cancer Res; 2007 Apr; 13(7):2075-81. PubMed ID: 17404089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
    Dong H; Strome SE; Salomao DR; Tamura H; Hirano F; Flies DB; Roche PC; Lu J; Zhu G; Tamada K; Lennon VA; Celis E; Chen L
    Nat Med; 2002 Aug; 8(8):793-800. PubMed ID: 12091876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma.
    Karim R; Jordanova ES; Piersma SJ; Kenter GG; Chen L; Boer JM; Melief CJ; van der Burg SH
    Clin Cancer Res; 2009 Oct; 15(20):6341-7. PubMed ID: 19825956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
    Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C
    Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other.
    Tollefson MK; Thompson RH; Sheinin Y; Lohse CM; Cheville JC; Leibovich BC; Kwon ED
    Cancer; 2007 Aug; 110(4):783-90. PubMed ID: 17594714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
    Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
    Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma.
    Ogushi T; Takahashi S; Takeuchi T; Urano T; Horie-Inoue K; Kumagai J; Kitamura T; Ouchi Y; Muramatsu M; Inoue S
    Cancer Res; 2005 May; 65(9):3700-6. PubMed ID: 15867365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.
    Konishi J; Yamazaki K; Azuma M; Kinoshita I; Dosaka-Akita H; Nishimura M
    Clin Cancer Res; 2004 Aug; 10(15):5094-100. PubMed ID: 15297412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
    Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
    Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
    Curiel TJ; Wei S; Dong H; Alvarez X; Cheng P; Mottram P; Krzysiek R; Knutson KL; Daniel B; Zimmermann MC; David O; Burow M; Gordon A; Dhurandhar N; Myers L; Berggren R; Hemminki A; Alvarez RD; Emilie D; Curiel DT; Chen L; Zou W
    Nat Med; 2003 May; 9(5):562-7. PubMed ID: 12704383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.